These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 10075157)
1. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Lavelle EC; Yeh MK; Coombes AG; Davis SS Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157 [TBL] [Abstract][Full Text] [Related]
2. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Yeh MK J Microencapsul; 2000; 17(6):743-56. PubMed ID: 11063421 [TBL] [Abstract][Full Text] [Related]
3. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants. Rafati H; Lavelle EC; Coombes AG; Stolnik S; Holland J; Davis SS Vaccine; 1997 Dec; 15(17-18):1888-97. PubMed ID: 9413098 [TBL] [Abstract][Full Text] [Related]
4. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems. Delgado A; Lavelle EC; Hartshorne M; Davis SS Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065 [TBL] [Abstract][Full Text] [Related]
5. The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids. Takahata H; Lavelle EC; Coombes AG; Davis SS J Control Release; 1998 Jan; 50(1-3):237-46. PubMed ID: 9685890 [TBL] [Abstract][Full Text] [Related]
6. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. O'Hagan DT; Jeffery H; Davis SS Vaccine; 1993; 11(9):965-9. PubMed ID: 8212845 [TBL] [Abstract][Full Text] [Related]
7. Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers. Yeh MK; Davis SS; Coombes AG Pharm Res; 1996 Nov; 13(11):1693-8. PubMed ID: 8956336 [TBL] [Abstract][Full Text] [Related]
8. Inactive Vibrio cholerae whole-cell vaccine-loaded biodegradable microparticles: in vitro release and oral vaccination. Yeh M; Chiang C J Microencapsul; 2004 Feb; 21(1):91-106. PubMed ID: 14718189 [TBL] [Abstract][Full Text] [Related]
9. Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Coombes AG; Lavelle EC; Jenkins PG; Davis SS Vaccine; 1996 Oct; 14(15):1429-38. PubMed ID: 8994318 [TBL] [Abstract][Full Text] [Related]
10. Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles. Moureau C; Vidal PL; Bennasser Y; Moynier M; Nicaise Y; Aussillous M; Barthelemy S; Montagnier L; Bahraoui E Mol Immunol; 2002 Jan; 38(8):607-18. PubMed ID: 11792429 [TBL] [Abstract][Full Text] [Related]
11. Immunization by particle bombardment of antigen-loaded poly-(DL-lactide-co-glycolide) microspheres in mice. Uchida M; Natsume H; Kishino T; Seki T; Ogihara M; Juni K; Kimura M; Morimoto Y Vaccine; 2006 Mar; 24(12):2120-30. PubMed ID: 16356602 [TBL] [Abstract][Full Text] [Related]
12. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802 [TBL] [Abstract][Full Text] [Related]
13. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles. Kim SY; Doh HJ; Ahn JS; Ha YJ; Jang MH; Chung SI; Park HJ Vaccine; 1999 Feb; 17(6):607-16. PubMed ID: 10075169 [TBL] [Abstract][Full Text] [Related]
15. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments. Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512 [TBL] [Abstract][Full Text] [Related]
16. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Stolnik S; Dunn SE; Garnett MC; Davies MC; Coombes AG; Taylor DC; Irving MP; Purkiss SC; Tadros TF; Davis SS Pharm Res; 1994 Dec; 11(12):1800-8. PubMed ID: 7899246 [TBL] [Abstract][Full Text] [Related]
17. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vordermeier HM; Coombes AG; Jenkins P; McGee JP; O'Hagan DT; Davis SS; Singh M Vaccine; 1995 Nov; 13(16):1576-82. PubMed ID: 8578845 [TBL] [Abstract][Full Text] [Related]
18. Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriers. Yan C; Rill WL; Malli R; Hewetson J; Tammariello R; Kende M Vaccine; 1995 May; 13(7):645-51. PubMed ID: 7668034 [TBL] [Abstract][Full Text] [Related]
19. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles. Yeh MK; Liu YT; Chen JL; Chiang CH J Control Release; 2002 Aug; 82(2-3):237-47. PubMed ID: 12175740 [TBL] [Abstract][Full Text] [Related]
20. Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study. San Román B; Gómez S; Irache JM; Espuelas S J Pharm Pharm Sci; 2014; 17(4):541-53. PubMed ID: 25579433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]